Polypharmacy Is Associated with Frailty, Nutritional Risk and Chronic Disease in Chilean Older Adults: Remarks from PIEI-ES Study

References

• Nations United. World population prospects: the 2010 revision; 2011 Available from: https://www.un.org/en/development/desa/publications/world-population-prospects-the-2010-revision.html.
   Google Scholar
• Medical expenditure panel survey; 2006 Available from: https://www.meps.ahrq.gov/mepsweb/.
   Google Scholar
• Rollason V, Vogt N. Reduction of polypharmacy in the elderly: a systematic review of the role of the pharmacist. Drugs Aging. 2003;20(11):817–832. doi:10.2165/00002512-200320110-0000312964888
   PubMed Web of Science ®Google Scholar
• Romero LME, Navarro J, Luengo C, et al. El Paciente Anciano: Demografía, Epidemiología y utilización de recursos In: Gerontología S editor. Tratado de geriatría para residentes.
   Google Scholar
• Ministerio de Salud de Chile. Encuesta Nacional de Salud; 2016–2017 Available from: https://www.minsal.cl/wp-content/uploads/2018/01/2-Resultados-ENS_MINSAL_31_01_2018.pdf.
   Google Scholar
• Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017;17(1):230. doi:10.1186/s12877-017-0621-229017448
   PubMed Web of Science ®Google Scholar
• Gnjidic D, Hilmer SN, Blyth FM, et al. Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. J Clin Epidemiol. 2012;65(9):989–995. doi:10.1016/j.jclinepi.2012.02.01822742913
   PubMed Web of Science ®Google Scholar
• Saum KU, Schottker B, Meid AD, et al. Is polypharmacy associated with frailty in older people? Results from the ESTHER cohort study. J Am Geriatr Soc. 2017;65(2):e27–e32. doi:10.1111/jgs.1471828024089
   PubMed Web of Science ®Google Scholar
• Xue QL. The frailty syndrome: definition and natural history. Clin Geriatr Med. 2011;27(1):1–15. doi:10.1016/j.cger.2010.08.00921093718
   PubMed Web of Science ®Google Scholar
• Garcia-Garcia FJ, Carcaillon L, Fernandez-Tresguerres J, et al. A new operational definition of frailty: the frailty trait scale. J Am Med Dir Assoc. 2014;15(5):371e7- e13. doi:10.1016/j.jamda.2014.01.004
   Web of Science ®Google Scholar
• Fried LP, Tangen CM, Walston J, et al. Frailty in older adults evidence for a phenotype. J Gerontol a Biol Sci Med Sci. 2001;56(3):M146–M57.11253156
   PubMed Web of Science ®Google Scholar
• Rosted E, Schultz M, Sanders S. Frailty and polypharmacy in elderly patients are associated with a high readmission risk. Dan Med J. 2016;63(9):A5274.27585531
   PubMed Web of Science ®Google Scholar
• Bonaga B, Sanchez-Jurado PM, Martinez-Reig M, et al. Frailty, polypharmacy, and health outcomes in older adults: the frailty and dependence in albacete study. J Am Med Dir Assoc. 2018;19(1):46–52. doi:10.1016/j.jamda.2017.07.00828899661
   PubMed Web of Science ®Google Scholar
• Herr M, Robine JM, Pinot J, Arvieu JJ, Ankri J. Polypharmacy and frailty: prevalence, relationship, and impact on mortality in a French sample of 2350 old people. Pharmacoepidemiol Drug Saf. 2015;24(6):637–646. doi:10.1002/pds.377225858336
   PubMed Web of Science ®Google Scholar
• Comans TA, Peel NM, Hubbard RE, Mulligan AD, Gray LC, Scuffham PA. The increase in healthcare costs associated with frailty in older people discharged to a post-acute transition care program. Age Ageing. 2016;45(2):317–320. doi:10.1093/ageing/afv19626769469
   PubMed Web of Science ®Google Scholar
• Ensrud KE, Kats AM, Schousboe JT, et al. Frailty phenotype and healthcare costs and utilization in older women. J Am Geriatr Soc. 2018;66(7):1276–1283. doi:10.1111/jgs.1538129684237
   PubMed Web of Science ®Google Scholar
• Liotta G, Gilardi F, Orlando S, et al. Cost of hospital care for the older adults according to their level of frailty. A cohort study in the Lazio region, Italy. PLoS One. 2019;14(6):e0217829. doi:10.1371/journal.pone.021782931185033
   PubMed Web of Science ®Google Scholar
• Palomo I, Giacaman RA, Leon S, et al. Analysis of the characteristics and components for the frailty syndrome in older adults from central Chile. The PIEI-ES study. Arch Gerontol Geriatr. 2019;80:70–75. doi:10.1016/j.archger.2018.10.00430390427
   PubMed Web of Science ®Google Scholar
• Instituto Nacional de Estadísticas. Resultados CENSO; 2017 Available from: http://resultados.censo2017.cl/.
   Google Scholar
• Fuentes JLG, Jirón M. Estudio de prevalencia de uso de medicamentos potencialmente inapropiados en adultos mayores atendidos en atención primaria en salud. 2009.
   Google Scholar
• Carvalho MFC, Romano-Lieber NS, Bergsten-Mendes G, et al. Polifarmácia entre idosos do Município de São Paulo - Estudo SABE. Rev Bras Epidemiol. 2012;15(4):817–827. doi:10.1590/S1415-790X201200040001323515777
   PubMedGoogle Scholar
• Palmer K, Villani ER, Vetrano DL, et al. Association of polypharmacy and hyperpolypharmacy with frailty states: a systematic review and meta-analysis. Eur Geriatr Med. 2019;10(1):9–36. doi:10.1007/s41999-018-0124-5
   PubMed Web of Science ®Google Scholar
• Guralnik JM, Simonsick EM, Ferrucci L, et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol. 1994;49(2):M85–94. doi:10.1093/geronj/49.2.M858126356
   PubMedGoogle Scholar
• Arroyo P, Lera L, Sanchez H, Bunout D, Santos JL, Albala C. Anthropometry, body composition and functional limitations in the elderly. Rev Med Chil. 2007;135(7):846–854. doi:10.4067/s0034-9887200700070000417914541
   PubMed Web of Science ®Google Scholar
• Albala C, Lera L, Sanchez H, et al. Frequency of frailty and its association with cognitive status and survival in older Chileans. Clin Interv Aging. 2017;12:995–1001. doi:10.2147/CIA.S13690628721027
   PubMed Web of Science ®Google Scholar
• Garcia-Garcia FJ, Gutierrez Avila G, Alfaro-Acha A, et al. The prevalence of frailty syndrome in an older population from Spain. The Toledo study for healthy aging. J Nutr Health Aging. 2011;15(10):852–856. doi:10.1007/s12603-011-0075-822159772
   PubMed Web of Science ®Google Scholar
• Santos-Eggimann B, Cuenoud P, Spagnoli J, Junod J. Prevalence of frailty in middle-aged and older community-dwelling Europeans living in 10 countries. J Gerontol a Biol Sci Med Sci. 2009;64(6):675–681. doi:10.1093/gerona/glp01219276189
   PubMed Web of Science ®Google Scholar
• Nascimento R, Álvares J, Guerra Junior AA, et al. Polypharmacy: a challenge for the primary health care of the Brazilian unified health system. Rev Saude Publica. 2017;51:19s.29160460
   PubMed Web of Science ®Google Scholar
• Cano-Guitierrez C, Samper-Ternent R, Cabrera J, Rosselli D. Uso de medicamentos en adultos mayores de Bogotá, Colombia. Rev Peru Med Exp Salud Publica. 2016;33(3):419–424. doi:10.17843/rpmesp.2016.333.229227831603
   PubMedGoogle Scholar
• Landi F, Dell’Aquila G, Collamati A, et al. Anticholinergic drug use and negative outcomes among the frail elderly population living in a nursing home. J Am Med Dir Assoc. 2014;15(11):825–829. doi:10.1016/j.jamda.2014.08.00225282629
   PubMed Web of Science ®Google Scholar
• Moulis F, Moulis G, Balardy L, et al. Exposure to atropinic drugs and frailty status. J Am Med Dir Assoc. 2015;16(3):253–257. doi:10.1016/j.jamda.2014.11.01725548029
   PubMed Web of Science ®Google Scholar
• Wang R, Chen L, Fan L, et al. Incidence and effects of polypharmacy on clinical outcome among patients aged 80+: a five-year follow-up study. PLoS One. 2015;10(11):e0142123. doi:10.1371/journal.pone.014212326554710
   PubMed Web of Science ®Google Scholar
• Aubert CE, Streit S, Da Costa BR, et al. Polypharmacy and specific comorbidities in university primary care settings. Eur J Intern Med. 2016;35:35–42. doi:10.1016/j.ejim.2016.05.02227289492
   PubMed Web of Science ®Google Scholar
• Gutierrez-Valencia M, Izquierdo M, Cesari M, Casas-Herrero A, Inzitari M, Martinez-Velilla N. The relationship between frailty and polypharmacy in older people: a systematic review. Br J Clin Pharmacol. 2018;84(7):1432–1444. doi:10.1111/bcp.1359029575094
   PubMed Web of Science ®Google Scholar
• Gnjidic D, Hilmer SN, Blyth FM, et al. High-risk prescribing and incidence of frailty among older community-dwelling men. Clin Pharmacol Ther. 2012;91(3):521–528. doi:10.1038/clpt.2011.25822297385
   PubMed Web of Science ®Google Scholar
• Ruiz ME. Risks of self-medication practices. Curr Drug Saf. 2010;5(4):315–323. doi:10.2174/15748861079224596620615179
   PubMedGoogle Scholar
• Morin L, Johnell K, Laroche M-L, Fastbom J, Wastesson JW. The epidemiology of polypharmacy in older adults: register-based prospective cohort study. Clin Epidemiol. 2018;10:289–298. doi:10.2147/CLEP.S15345829559811
   PubMed Web of Science ®Google Scholar
• Salech F, Daniel Palma QF, Pablo Garrido QF. Epidemiología del uso de Medicamentos en el adulto mayor. Rev Méd Clín Las Condes. 2016;27(5):660–670. doi:10.1016/j.rmclc.2016.09.011
   Google Scholar
• Homero GE. Polifarmacia y morbilidad en adultos mayores. Rev Méd Clín Las Condes. 2012;23(1):31–35. doi:10.1016/S0716-8640(12)70270-5
   Google Scholar
• Rolland Y, Morley JE. Frailty and polypharmacy. J Nutr Health Aging. 2016;20(6):645–646. doi:10.1007/s12603-015-0510-327273354
   PubMed Web of Science ®Google Scholar